Vildagliptina/Metformina Vir

Vildagliptina/Metformina Vir is a combination oral medication used to manage blood sugar levels in adults with type 2 diabetes. This EU-manufactured treatment combines two active ingredients to support glycemic control. It is designed for oral use and helps regulate glucose metabolism. Suitable for those seeking combined diabetes therapy.

Vildagliptina/Metformina Vir is used to improve blood sugar control in adults with type 2 diabetes when diet and exercise alone are not sufficient. The combination of vildagliptin and metformin works by enhancing insulin production and reducing glucose production in the liver. It is often prescribed alongside lifestyle changes to support metabolic health. This medication is not a substitute for diet and exercise but helps manage glucose levels effectively.

This medication helps maintain steady blood sugar levels throughout the day by supporting the body's natural insulin response. Users may experience improved energy levels and reduced symptoms of high blood sugar, such as frequent thirst or fatigue. It works gradually over time to support stable glucose control. Individual responses may vary based on diet, activity, and overall health.

Store this medication at room temperature away from moisture and heat. Keep it out of reach of children and pets to prevent accidental ingestion. If you experience persistent nausea, dizziness, or signs of low blood sugar, consult a healthcare provider. Regular monitoring of blood sugar levels is recommended while using this medication.

Vildagliptina/Metformina Vir may interact with alcohol, increasing the risk of lactic acidosis or low blood sugar. Certain medications, such as diuretics or corticosteroids, can affect blood sugar levels and may require dose adjustments. Always inform your healthcare provider about all medications, supplements, or herbal products you are taking. Some combinations may require closer monitoring.